CIAM
CAI

Caitong International Asset Management’s Caris Life Sciences CAI Stock Holding History

Caitong International Asset Management’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$429 Buy
+24
New +$525 ﹤0.01% 1701
2025
Q4 		– Sell
-208
Closed -$6.29K – 2487
2025
Q3 		$6.29K Buy
+208
New +$6.63K ﹤0.01% 1160

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $326M AUM
SSP
Sixth Street Partners Dallas, Texas $711M AUM 9.3% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Caitong International Asset Management's CAI Position: Q1 2026 in Review

Caitong International Asset Management opened a new position in Caris Life Sciences (CAI) in Q1 2026: 24 shares worth $429. The stake represents ﹤0.01% of the portfolio and ranks #1701 among its holdings. This is a return to the name: Caitong International Asset Management previously reported a position in CAI as recently as Q3 2025.

Caitong International Asset Management first reported a position in CAI in Q3 2025 and has held it in 2 quarters since. The position peaked at $6.29K in Q3 2025. 202 funds tracked by Wall St. Rank hold CAI as of Q1 2026.

  • Caitong International Asset Management held 24 shares of Caris Life Sciences worth $429 as of Q1 2026.
  • Caris Life Sciences was a new Caitong International Asset Management position in Q1 2026.
  • Caris Life Sciences made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #1701 holding.
  • Caitong International Asset Management first reported a position in Caris Life Sciences in Q3 2025 and has held it in 2 quarters since.
  • Caitong International Asset Management's Caris Life Sciences position peaked at $6.29K in Q3 2025.
  • 202 funds tracked by Wall St. Rank held Caris Life Sciences as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.